| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/29/2006 | US7098223 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 08/29/2006 | US7098220 Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same |
| 08/29/2006 | US7098216 Thiazolopyrimidines useful as TNFα inhibitors |
| 08/29/2006 | US7098204 Hymenialdisine or derivatives thereof in the manufacture of medicaments |
| 08/29/2006 | US7098197 An antiviral nucleoside in which the 5'-hydroxyl group has been substituted for a phosphonate or methyl phosphonate that is covalently linked to an alkylethanediol; osteoporosis; anticarcinogenic agents; viricides |
| 08/29/2006 | US7098029 Product and method for control of obesity |
| 08/29/2006 | US7097860 Administering solution containing magnesium, or compound thereof |
| 08/29/2006 | US7097845 Combinations of antigen and mucosal binding component for inducing specific immunological tolerance |
| 08/29/2006 | US7097838 Antagonists of HMG1 for treating inflammatory conditions |
| 08/29/2006 | US7097834 Osteoprotegerin binding proteins |
| 08/29/2006 | CA2521980C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 08/29/2006 | CA2521958C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-pheyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 08/29/2006 | CA2396738C Thiazole derivatives as active superoxide radical inhibitors |
| 08/29/2006 | CA2392271C Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 08/29/2006 | CA2238845C Novel 2,3,5-trimethyl-4-hydroxy anilide derivatives, preparation thereof and therapeutical use thereof |
| 08/29/2006 | CA2053585C Antibody production in chinese hamster ovary cells |
| 08/24/2006 | WO2006089225A1 5- [4- (4- (2 -amino- 2 -methoxycarbonylethyl) phenoxy) benzilidene] thiazolidin-2 , 4-dion e derivatives and related compounds for reducing glucose, cholesterol and triglyceride levels in plasma |
| 08/24/2006 | WO2006088875A2 Intranasal administration of modulators of hypothalamic atp-sensitive potassium channels |
| 08/24/2006 | WO2006088748A2 Method for treating obesity |
| 08/24/2006 | WO2006088648A1 Compositions and methods for treating dyslipidemia |
| 08/24/2006 | WO2006088315A1 Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases |
| 08/24/2006 | WO2006088219A1 Il-13 production inhibitor |
| 08/24/2006 | WO2006088198A1 Method of producing protein by using hamster igf-1 |
| 08/24/2006 | WO2006088188A1 Oil-and-fat composition |
| 08/24/2006 | WO2006088129A1 Salt of proline derivative, solvate thereof, and production method thereof |
| 08/24/2006 | WO2006088080A1 CYCLOHEPTA[b]PYRIDINE-3-CARBONYLGUANIDINE DERIVATIVE AND PHARMACEUTICAL PRODUCT CONTAINING SAME |
| 08/24/2006 | WO2006088011A1 Inhibitor of plasminogen activator inhibitor-1 |
| 08/24/2006 | WO2006087997A1 1-SUBSTITUTED-7-(β-D-GLYCOPYRANOSYLOXY)(AZA)INDOLE COMPOUND AND PHARMACEUTICAL CONTAINING THE SAME |
| 08/24/2006 | WO2006087732A1 An amorphous and three crystalline forms of rimonabant hydrochloride |
| 08/24/2006 | WO2006087481A1 Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes |
| 08/24/2006 | WO2006087404A1 Stabilised amorphous calcium atorvastatin and production method thereof |
| 08/24/2006 | WO2006087309A1 3,4-dihydro-1h-isoquinoline-2-carboxylic acid 5-aminopyridin-2-yl esters |
| 08/24/2006 | WO2006087116A1 Oral dosage form comprising rosiglitazone |
| 08/24/2006 | WO2006087077A2 Hsp90-inhibiting triazole derivatives |
| 08/24/2006 | WO2006086978A2 Use of deuterated n-[2-(5-methoxy-1h-indol-3-yl)-ethyl]acetamides and the pharmaceutically acceptable salts thereof, and medicaments containing said compounds |
| 08/24/2006 | WO2006086856A1 Combination therapeutic compositions and method of use |
| 08/24/2006 | WO2006076598A3 Bicyclic heterocycles as cannabinoid receptor modulators |
| 08/24/2006 | WO2006055347A3 Desacyl ghrelin antibodies and therapeutic uses thereof |
| 08/24/2006 | WO2006053043A3 Methods of treating diabetes mellitus |
| 08/24/2006 | WO2006009464A3 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities |
| 08/24/2006 | WO2005116002B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 08/24/2006 | US20060191027 Cystine-knot polypeptides: Cloaked-2 molecules and uses thereof |
| 08/24/2006 | US20060189678 4,5-dihydronaphtho[1,2-b]thiophene derivative |
| 08/24/2006 | US20060189673 Phenylazole compound, production process therefor and antioxidant |
| 08/24/2006 | US20060189667 PPAR-activating compound and pharmaceutical composition comprising the compound |
| 08/24/2006 | US20060189663 Pyrrole-2,5-dithione derivatives as liver x receptor modulators |
| 08/24/2006 | US20060189660 5-(4-(2-N-methyl-N-(2-pyridyl)amido)ethoxy)benzyl thiazolidine - 2,4-dione and pharmaceutical compositions comprising the same |
| 08/24/2006 | US20060189659 Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione maleic acid salt |
| 08/24/2006 | US20060189656 Piperidine derivatives and agent comprising the derivative as active ingredient |
| 08/24/2006 | US20060189647 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof |
| 08/24/2006 | US20060189632 MAPKAP-K2; inflammatory disease, autoimmune disease, destructive bone disorder, cancer and/or tumour growth; 5-[(trans-4-aminocyclohexyl)amino]-3-fluoro-6-methyl(pyrazolo[1,5-a]pyri- midin-7-yl)}(4-iodophenyl)amine |
| 08/24/2006 | US20060189609 1, 8-Naphthyridine derivatives and their use to treat diabetes and related disorders |
| 08/24/2006 | US20060189598 substituted azole acid derivatives which modulate blood glucose levels, triglyceride levels, insulin levels and non-esterified fatty acid levels; hypolipidemic agent; hyperglycemia, hyperinsulinemia, hyperlipidemia, obesity, atherosclerosis; Type 2 diabetes |
| 08/24/2006 | US20060189597 Lactam compounds and pharmaceutical use thereof |
| 08/24/2006 | US20060189583 Aryl dicarboxamides |
| 08/24/2006 | US20060189578 Method for the synthesis of compounds of formula I and their uses thereof |
| 08/24/2006 | US20060189574 Method of treating high plasma cholesterol levels |
| 08/24/2006 | US20060189567 Compound having affinity with calcified tissue |
| 08/24/2006 | US20060189549 Chalcone derivatives and their use to treat diseases |
| 08/24/2006 | US20060189535 Combination treatment using exendins and thiazolidinediones |
| 08/24/2006 | US20060189530 Neuropeptide Y receptor Y5 and nucleic acid sequences |
| 08/24/2006 | US20060189525 DADD, death activator death domain protein |
| 08/24/2006 | US20060189520 Treatment of diabetes |
| 08/24/2006 | US20060188614 Method and bottle for infant feeding |
| 08/24/2006 | US20060188591 Bauhinia extracts |
| 08/24/2006 | US20060188574 Controlled release lipoic acid |
| 08/24/2006 | US20060188484 Virus vectors and methods of making and administering the same |
| 08/24/2006 | US20060188483 Virus vectors and methods of making and administering the same |
| 08/24/2006 | US20060188472 HAS-active ingredient conjugates |
| 08/24/2006 | DE102005006539A1 Biguanid enthaltende Zusammensetzungen Biguanide-containing compositions |
| 08/24/2006 | CA2836652A1 Production method of capsinoid by dehydrating condensation, stabilizing method of capsinoid, and capsinoid composition |
| 08/24/2006 | CA2598988A1 Cyclohepta[b]pyridine-3-carbonylguanidine derivative and pharmaceutical product containing the same as nhe inhibitors |
| 08/24/2006 | CA2598570A1 Methods for producing proteins using hamster igf-1 |
| 08/24/2006 | CA2598301A1 Salt of proline derivative, solvate thereof, and production method thereof |
| 08/24/2006 | CA2598087A1 5-[4-(4-(2-amino-2 methoxycarbonylethyl)phenoxy)benzilidene]thiazolidin-2,4-dione derivatives and related compounds for reducing glucose, cholesterol and triglyceride levels in plasma |
| 08/24/2006 | CA2598017A1 Triazole derivatives |
| 08/24/2006 | CA2597925A1 Use of human hemojuvelin product to regulate hepcidin-mediated iron metabolism |
| 08/24/2006 | CA2597269A1 1-substituted-7-(beta-d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same |
| 08/24/2006 | CA2597245A1 Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes |
| 08/24/2006 | CA2596522A1 3,4-dihydro-1h-isoquinoline-2-carboxylic acid 5-aminopyridin-2-yl esters |
| 08/24/2006 | CA2595564A1 Use of .beta.-lapachone and related naphthoquinones in the treatment of amp-activated protein kinase (ampk) mediated disorders |
| 08/24/2006 | CA2595411A1 Oral dosage form comprising rosiglitazone |
| 08/23/2006 | EP1693456A1 Gene encoding g protein-coupled receptor and gene product thereof |
| 08/23/2006 | EP1693376A2 Crystalline composites comprising phytosterols and phytostanols or derivatives thereof |
| 08/23/2006 | EP1693372A1 Novel Sulfamides and their use as endothelin receptor antagonists |
| 08/23/2006 | EP1693365A1 Inhibitors of dipeptidyl peptidase IV |
| 08/23/2006 | EP1693084A1 Alga extract and lipase inhibitor containing the same |
| 08/23/2006 | EP1693068A1 Use of M. tuberculosis chaperonin 60.1 for the treatment of arthritis |
| 08/23/2006 | EP1692521A1 Rbp4 in insulin sensitivity/resistance, diabetes, and obesity |
| 08/23/2006 | EP1692267A2 Methods of organ regeneration |
| 08/23/2006 | EP1692114A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 08/23/2006 | EP1691819A2 Chaperone-based therapy for niemann-pick disease |
| 08/23/2006 | EP1691803A1 N-alkyl pyrroles as hmg-coa reductase inhibitors |
| 08/23/2006 | EP1558612B1 Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same |
| 08/23/2006 | EP1417205B1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 08/23/2006 | EP1404309B1 A pharmaceutical combination comprising either (s)-2-ethoxy-3- 4-(2- 4-methane sulfonyl oxyphenyl ethoxy) phenyl| propanoic acid or 3- 4- 2- (4-tert-butoxy carbonyl aminophenyl) ethoxy| phenyl -(s)-2-ethoxy propanoic acid and a biguanide drug |
| 08/23/2006 | EP1368358B1 Isoxazoline derivatives as anti-depressants |
| 08/23/2006 | EP1349855B1 5-'4-'2-(n-methyl-n- (2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione mesylate salt |
| 08/23/2006 | EP1339294B1 Nutritional composition for an immune condition |
| 08/23/2006 | EP1278716B1 Trans-n-¬4-(4-hydroxyphenyl)cyclohexyl|-3-phenylpropionamide as subtype selective nmda receptor antagonist |